70-75% of Sertoli-Leydig cell tumors (SLCT) are diagnosed at before age of 40, and less than 10% takes place before menarche and following menapouse. We report a case of right adnexal mass in a 59 year-old postmenapousal woman who presented with vaginal bleeding. Sex-cord stromal tumor was diagnosed at peroperative frozen section assesment. Staging surgery consisting of peritoneal biopsies, omentectomy and pelvic paraaortic lymph node dissection was performed. In histopathologic assesment of the slides which were prepared from solid-cyctic areas of the mass, revealed immature sertoli cells forming tubules and a wide sarcomatoid differantiation. Immunhistochemically, neoplastic cells stained strongly and diffusely positive with CD 56, focal ...
A case of retiform variant of Sertoli-Leydig cell tumour (SLCT) of ovary was encountered in a 16 yea...
Sertoli-Leydig cell tumors (SLCTs), constitute less than 0.5% of all ovarian tumors. SLCT are rare a...
Sertoli--Leydig hücreli tümör (SLHT)'lerin %70--75'i 40 yaşın altında, 0/010'dan azı menarştan önce ...
Background. Sertoli-Leydig cell tumors belong to the group of sex cord stromal tumors of the ovary. ...
Sertoli-Leydig cell tumor belongs to the group of sex cord-stromal tumors of the ovary. These neopla...
Ovarian sex cord stromal cell tumors occur most frequently in the third and fourth decades of life. ...
Copyright © 2013 Ahmed Abu-Zaid et al. This is an open access article distributed under the Creative...
Ovarian Sertoli-Leydig cell tumors (SLCT) represent <2% of primary ovarian tumors, which range from ...
Introduction: Sertoli-Leydig cell tumors (SLCTs) are rare tumors mostly occurring in young women. He...
Introduction Sertoli-Leydig cell tumors (SLCTs) are rare tumors mostly occurring in young women. Her...
Sertoli-Leydig cell tumor (SLCT) of ovary is an unusual neoplasm that belongs to a group of sex cord...
Sertoli-Leydig cell tumor (SLCT) of the ovary is an exceedingly unusual neoplasm that belongs to a g...
Sertoli-Leydig Cell Tumors are rare constituting less than 0.5% of ovarian neoplasms and usually uni...
Objective; We present a case report regarding a 71-year-old woman with postmenopausal virilization c...
AbstractObjectiveSertoli–Leydig cell tumor (SLCT) accounts for <0.5% of all ovarian tumors, which is...
A case of retiform variant of Sertoli-Leydig cell tumour (SLCT) of ovary was encountered in a 16 yea...
Sertoli-Leydig cell tumors (SLCTs), constitute less than 0.5% of all ovarian tumors. SLCT are rare a...
Sertoli--Leydig hücreli tümör (SLHT)'lerin %70--75'i 40 yaşın altında, 0/010'dan azı menarştan önce ...
Background. Sertoli-Leydig cell tumors belong to the group of sex cord stromal tumors of the ovary. ...
Sertoli-Leydig cell tumor belongs to the group of sex cord-stromal tumors of the ovary. These neopla...
Ovarian sex cord stromal cell tumors occur most frequently in the third and fourth decades of life. ...
Copyright © 2013 Ahmed Abu-Zaid et al. This is an open access article distributed under the Creative...
Ovarian Sertoli-Leydig cell tumors (SLCT) represent <2% of primary ovarian tumors, which range from ...
Introduction: Sertoli-Leydig cell tumors (SLCTs) are rare tumors mostly occurring in young women. He...
Introduction Sertoli-Leydig cell tumors (SLCTs) are rare tumors mostly occurring in young women. Her...
Sertoli-Leydig cell tumor (SLCT) of ovary is an unusual neoplasm that belongs to a group of sex cord...
Sertoli-Leydig cell tumor (SLCT) of the ovary is an exceedingly unusual neoplasm that belongs to a g...
Sertoli-Leydig Cell Tumors are rare constituting less than 0.5% of ovarian neoplasms and usually uni...
Objective; We present a case report regarding a 71-year-old woman with postmenopausal virilization c...
AbstractObjectiveSertoli–Leydig cell tumor (SLCT) accounts for <0.5% of all ovarian tumors, which is...
A case of retiform variant of Sertoli-Leydig cell tumour (SLCT) of ovary was encountered in a 16 yea...
Sertoli-Leydig cell tumors (SLCTs), constitute less than 0.5% of all ovarian tumors. SLCT are rare a...
Sertoli--Leydig hücreli tümör (SLHT)'lerin %70--75'i 40 yaşın altında, 0/010'dan azı menarştan önce ...